1. Chen, Baoxiang, Hong, Yuntian, Zhai, Xiang, Zhao, Jianhong, Jiang, Congqing. 2023. m6A and m5C modification of GPX4 facilitates anticancer immunity via STING activation. In Cell death & disease, 14, 809. doi:10.1038/s41419-023-06241-w. https://pubmed.ncbi.nlm.nih.gov/38065948/
2. Wang, Tianyu, Bai, Jianhao, Zhang, Yuanyuan, Xue, Yawen, Peng, Qing. 2022. N6-Methyladenosine regulator RBM15B acts as an independent prognostic biomarker and its clinical significance in uveal melanoma. In Frontiers in immunology, 13, 918522. doi:10.3389/fimmu.2022.918522. https://pubmed.ncbi.nlm.nih.gov/36003405/
3. Wu, Haoming, Feng, Jikun, Wu, Jundong, Yi, Jiarong, Wang, Xi. 2022. Prognostic value of comprehensive typing based on m6A and gene cluster in TNBC. In Journal of cancer research and clinical oncology, 149, 4367-4380. doi:10.1007/s00432-022-04345-y. https://pubmed.ncbi.nlm.nih.gov/36109402/
4. Gu, Yong, Wang, Zhengming, Wang, Rui, Xiao, Long, Wang, Zhirong. 2023. N6-methyladenine regulator-mediated RNA methylation modification patterns in immune microenvironment regulation of osteoarthritis. In Frontiers in genetics, 14, 1113515. doi:10.3389/fgene.2023.1113515. https://pubmed.ncbi.nlm.nih.gov/36777725/
5. Cheng, Linlin, Li, Haolong, Zhan, Haoting, Zhang, Fengchun, Li, Yongzhe. 2022. Alterations of m6A RNA methylation regulators contribute to autophagy and immune infiltration in primary Sjögren's syndrome. In Frontiers in immunology, 13, 949206. doi:10.3389/fimmu.2022.949206. https://pubmed.ncbi.nlm.nih.gov/36203590/